THE HEMODYNAMIC-EFFECTS OF CORRECTION OF ANEMIA IN HEMODIALYSIS-PATIENTS USING RECOMBINANT-HUMAN-ERYTHROPOIETIN

被引：0
|
作者：
ABDULHADI, MH
FOUADTARAZI, FM
THOMAS, T
BRAVO, EL
PAGANINI, EP
机构：
[1] CLEVELAND CLIN EDUC FDN, DEPT HYPERTENS, CLEVELAND, OH 44106 USA
[2] CLEVELAND CLIN EDUC FDN, DEPT HEART & HYPERTENS, CLEVELAND, OH 44106 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1990年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：102 / 108
页数：7
相关论文
共 50 条
  • [21] COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR ANEMIA IN HEMODIALYSIS-PATIENTS WITH SIGNIFICANT COMORBID DISEASE
    MUIRHEAD, N
    CHURCHILL, DN
    GOLDSTEIN, M
    NADLER, SP
    POSEN, G
    WONG, C
    SLAUGHTER, D
    LAPLANTE, P
    AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (05) : 303 - 310
  • [22] LONG-TERM MYOCARDIAL EFFECTS OF CORRECTION OF ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN AGED PATIENTS ON HEMODIALYSIS
    MARTINEZVEA, A
    BARDAJI, A
    GARCIA, C
    RIDAO, C
    RICHART, C
    OLIVER, JA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (04) : 353 - 357
  • [23] TREATMENT OF THE ANEMIA OF PATIENTS MAINTAINED BY HEMODIALYSIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    SCHAEFER, RM
    KUERNER, B
    ZECH, M
    HEIDLAND, A
    ARTIFICIAL ORGANS, 1987, 11 (04) : 307 - 307
  • [24] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) FOR CORRECTION OF ANEMIA IN PATIENTS ON LONG-TERM HEMODIALYSIS (HD)
    WEISS, L
    WENTZEL, T
    FRISENETTEFICH, C
    HOFFSTEDT, E
    LINDBERGER, K
    MASCHER, G
    NIELSEN, F
    PRUTZ, K
    WESSEN, P
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 506 - 507
  • [25] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    NEPHRON, 1993, 63 (01) : 113 - 114
  • [26] NUTRITIONAL ASSESSMENT IN ANEMIC HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    BARANY, P
    PETTERSON, E
    AHLBERG, M
    HULTMAN, E
    BERGSTROM, J
    CLINICAL NEPHROLOGY, 1991, 35 (06) : 270 - 279
  • [27] EVALUATION OF PLATELET HYPERFUNCTION IN HEMODIALYSIS-PATIENTS RECEIVING RECOMBINANT-HUMAN-ERYTHROPOIETIN
    ZIRKMAN, DM
    ZEIGLER, ZR
    FRALEY, DS
    BRUNS, FJ
    ADLER, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (01) : 31 - 37
  • [28] TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS WITH RECOMBINANT ERYTHROPOIETIN
    WINEARLS, CG
    NEPHRON, 1989, 51 : 26 - 28
  • [29] BENEFITS AND RISKS OF ANEMIA CORRECTION WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHILDREN MAINTAINED BY HEMODIALYSIS
    MONTINI, G
    ZACCHELLO, G
    BARALDI, E
    ZANCONATO, S
    SUPPIEJ, A
    FABRIS, F
    ANDREETTA, B
    PAVANELLO, L
    ZACCHELLO, F
    JOURNAL OF PEDIATRICS, 1990, 117 (04): : 556 - 560
  • [30] RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT REVERSES HEPATIC IRON OVERLOAD IN HEMODIALYSIS-PATIENTS
    BERLAND, Y
    BAZ, M
    DISTEFANO, D
    MERZOUK, T
    BARTOLI, JM
    DUSSOL, B
    KASBARIAN, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (04) : 366 - 367
12345